Otto Cars
Professor at Department of Medical Sciences; Infection medicine
- Telephone:
- +46 18 611 56 45
- Mobile phone:
- +46 70 892 02 03
- E-mail:
- Otto.Cars@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset
Infektion, ingång 34, 1 tr - Postal address:
- Akademiska sjukhuset
Infektion, ingång 34, 1 tr
751 85 Uppsala
Download contact information for Otto Cars at Department of Medical Sciences; Infection medicine
Professor at Department of Medical Sciences; ReAct
- Telephone:
- +46 18 471 66 05, +46 18 611 93 60
- Mobile phone:
- +46 70 892 02 03
- E-mail:
- Otto.Cars@medsci.uu.se
- Visiting address:
- Fyristorg 6, plan 3
- Postal address:
- Box 256
75105 UPPSALA
Download contact information for Otto Cars at Department of Medical Sciences; ReAct
Publications
Recent publications
-
Meeting the 2024 UN General Assembly declaration targets on antimicrobial resistance
Part of The Lancet, p. 195-198, 2026
-
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation
Part of The Lancet, 2024
-
The language of antimicrobial and antibiotic resistance is blocking global collective action
Part of Infectious Diseases, p. 487-495, 2024
- DOI for The language of antimicrobial and antibiotic resistance is blocking global collective action
- Download full text (pdf) of The language of antimicrobial and antibiotic resistance is blocking global collective action
-
The 2024 political declaration on antimicrobial resistance needs bold targets
Part of BMJ. British Medical Journal, 2024
-
Part of Scientific Reports, 2024
- DOI for Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic model
- Download full text (pdf) of Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic model
All publications
Articles in journal
-
Meeting the 2024 UN General Assembly declaration targets on antimicrobial resistance
Part of The Lancet, p. 195-198, 2026
-
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation
Part of The Lancet, 2024
-
The language of antimicrobial and antibiotic resistance is blocking global collective action
Part of Infectious Diseases, p. 487-495, 2024
- DOI for The language of antimicrobial and antibiotic resistance is blocking global collective action
- Download full text (pdf) of The language of antimicrobial and antibiotic resistance is blocking global collective action
-
The 2024 political declaration on antimicrobial resistance needs bold targets
Part of BMJ. British Medical Journal, 2024
-
Part of Scientific Reports, 2024
- DOI for Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic model
- Download full text (pdf) of Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic model
-
Part of Journal of Law, Medicine & Ethics, p. 34-39, 2022
- DOI for Equitable Access to Antibiotics: A Core Element and Shared Global Responsibility for Pandemic Preparedness and Response
- Download full text (pdf) of Equitable Access to Antibiotics: A Core Element and Shared Global Responsibility for Pandemic Preparedness and Response
-
Unavailability of old antibiotics threatens effective treatment for common bacterial infections
Part of The Lancet - Infectious diseases, p. 242-244, 2018
-
Global governance of antimicrobial resistance
Part of The Lancet, p. 1976-1978, 2018
-
Reply to Prim et al., "Is Colistin Susceptibility Testing Finally on the Right Track?"
Part of Antimicrobial Agents and Chemotherapy, 2018
-
Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli
Part of International Journal of Antimicrobial Agents, p. 399-406, 2018
-
Colistin is Extensively Lost during Standard in Vitro Experimental Conditions
Part of Antimicrobial Agents and Chemotherapy, 2017
-
Evaluation of automated time-lapse microscopy for assessment of in vitro activity of antibiotics
Part of Journal of Microbiological Methods, p. 69-75, 2017
-
Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia
Part of International Journal of Antimicrobial Agents, p. 98-101, 2017
-
Ensuring universal access to old antibiotics: a critical but neglected priority
Part of Clinical Microbiology and Infection, p. 590-592, 2017
-
Part of Infectious Diseases, p. 521-527, 2017
-
Part of Journal of Antimicrobial Chemotherapy, p. 1279-1290, 2016
-
Part of PLOS ONE, 2016
- DOI for A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures
- Download full text (pdf) of A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures
-
UN High-Level Meeting on antimicrobials-what do we need?
Part of The Lancet, p. 218-220, 2016
-
Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
Part of Journal of Antimicrobial Chemotherapy, p. 661-665, 2016
- DOI for Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
- Download full text (pdf) of Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
-
An international legal framework to address antimicrobial resistance
Part of Bulletin of the World Health Organization, p. 66-66, 2015
-
Part of JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, p. 95-102, 2015
-
Part of Antimicrobial Agents and Chemotherapy, p. 2971-2971, 2015
-
Part of Journal of Antimicrobial Chemotherapy, p. 3051-3060, 2015
-
Antibiotic resistance: An ethical challenge
Part of International Journal of Antimicrobial Agents, p. 359-361, 2015
-
Pharmacodynamic studies of nitrofurantoin against common uropathogens
Part of Journal of Antimicrobial Chemotherapy, p. 1076-1082, 2015
-
Universal Access to Effective Antibiotics is Essential for Tackling Antibiotic Resistance
Part of Journal of Law, Medicine & Ethics, p. 17-21, 2015
-
Part of The Lancet - Infectious diseases, p. 1179-1180, 2014
-
Part of Journal of Antimicrobial Chemotherapy, p. 1350-1361, 2014
-
Part of Antimicrobial Agents and Chemotherapy, p. 1757-1762, 2014
-
Part of International Journal of Antimicrobial Agents, p. 354-357, 2014
-
Securing access to effective antibiotics for current and future generations. Whose responsibility?
Part of Upsala Journal of Medical Sciences, p. 209-214, 2014
-
Consistent Global Approach on Reporting of Colistin Doses to Promote Safe and Effective Use
Part of Clinical Infectious Diseases, p. 139-+, 2014
-
Part of Clinical Microbiology and Infection, 2014
-
Antibiotic resistance: problems, progress, and prospects
Part of New England Journal of Medicine, p. 1761-1763, 2014
-
Antibiotic resistance-the need for global solutions
Part of The Lancet - Infectious diseases, p. 1057-1098, 2013
-
Global survey of polymyxin use: A call for international guidelines
Part of JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, p. 131-134, 2013
- DOI for Global survey of polymyxin use: A call for international guidelines
- Download full text (pdf) of Global survey of polymyxin use: A call for international guidelines
-
Part of Journal of Antimicrobial Chemotherapy, p. 1319-1326, 2013
-
Part of Antimicrobial Agents and Chemotherapy, p. 668-671, 2013
-
3Rs for innovating novel antibiotics: sharing resources, risks, and rewards
Part of The BMJ, 2012
-
Part of Antimicrobial Agents and Chemotherapy, p. 179-188, 2012
-
Part of Antimicrobial Agents and Chemotherapy, p. 4241-4249, 2012
-
Part of Läkartidningen, p. 108-109, 2012
-
Part of Journal of Antimicrobial Chemotherapy, p. 1161-1167, 2011
-
Fighting bacterial resistance at the root: need for adapted EMEA guidelines
Part of The Lancet - Infectious diseases, p. 6-8, 2011
-
Part of Antimicrobial Agents and Chemotherapy, p. 4619-4630, 2011
-
Part of Antimicrobial Agents and Chemotherapy, p. 1629-1637, 2011
-
Part of Antimicrobial Agents and Chemotherapy, p. 1571-1579, 2011
-
Part of Antimicrobial Agents and Chemotherapy, p. 3099-3104, 2011
-
Part of Antimicrobial Agents and Chemotherapy, p. 3564-3568, 2010
-
Part of Antimicrobial Agents and Chemotherapy, p. 3564-3568, 2010
-
Tackling antibiotic resistance
Part of BMJ. British Medical Journal, 2010
-
Serum and Cerebrospinal Fluid Levels of Colistin in Pediatric Patients
Part of Antimicrobial Agents and Chemotherapy, p. 3985-3987, 2010
-
Part of Läkartidningen, p. 2392-2395, 2010
-
Part of Journal of Antimicrobial Chemotherapy, p. 350-360, 2010
-
Part of Journal of Pharmaceutical and Biomedical Analysis, p. 760-767, 2009
-
Antibiotic resistance in China: a major future challenge
Part of The Lancet, p. 30-30, 2009
-
Doxycyklin är ingen hostmedicin: Antibiotika vid akut bronkit är både onödigt och riskabelt
Part of Läkartidningen, p. 1666-7, 2009
-
Part of Scandinavian Journal of Infectious Diseases, p. 663-671, 2009
-
Meeting the challenge of antibiotic resistance
Part of The BMJ, 2008
-
Verkningslösa antibiotika dödligt hot även i Sverige
Part of DN-debatt, 2 mars, 2008
-
Tissue concentrations: do we ever learn?
Part of Journal of Antimicrobial Chemotherapy, p. 235-237, 2008
-
Part of Journal of Antimicrobial Chemotherapy, p. 142-8, 2008
-
Alcohol-based hand-disinfection reduced children's absence from Swedish day care centers
Part of Acta Paediatrica, p. 1672-80, 2008
-
Strama-a Swedish working model for containment of antibiotic resistance.
Part of Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin, 2008
-
Förkorta behandlingstiderna vid nedre urinvägsinfektion hos kvinnor och använd inte kinoloner!
Part of Läkartidningen, p. 1114-5, 2008
-
Part of Journal of clinical pharmacology, p. 1270-81, 2008
-
Antimicrobial drug use and resistance in Europe
Part of Emerging Infectious Diseases, p. 1722-30, 2008
-
Dose-related selection of fluoroquinolone-resistant Escherichia coli
Part of Journal of Antimicrobial Chemotherapy, p. 795-801, 2007
-
Part of Antimicrobial Agents and Chemotherapy, p. 128-136, 2007
-
Optimizing drug exposure to minimize selection of antibiotic resistance
Part of Clinical Infectious Diseases, 2007
-
STRAMA håller fast vid Otitkonsensus
Part of Läkartidningen, p. 1996-1997, 2007
-
Part of Clinical Microbiology and Infection, p. 613-619, 2007
-
Part of Läkartidningen, p. 3478, 2007
-
Part of Antimicrobial Agents and Chemotherapy, p. 3311-3316, 2007
-
Antibiotikaresistenta S aureus ger ökad dödlighet och dyrare sjukvård
Part of Läkartidningen, p. 3052-3056, 2007
-
A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function
Part of British Journal of Clinical Pharmacology, p. 297-303, 2006
-
Part of Journal of Antimicrobial Chemotherapy, p. 960-965, 2006
-
National campaigns to improve antibiotic use.
Part of Eur J Clin Pharmacol, p. 373-9, 2006
-
Kinoloner - bot som blivit hot: Accelererande resistensutveckling kräver skärpta indikationer
Part of Läkartidningen, p. 3651-3659, 2005
-
Part of J Antimicrob Chemother, p. 208-15, 2005
-
Part of J Antimicrob Chemother, p. 601-7, 2005
-
Part of J Antimicrob Chemother, p. 240-2, 2005
-
Part of Antimicrob Agents Chemother, p. 5081-91, 2005
-
Part of J Antimicrob Chemother, p. 1062-6, 2004
-
Part of Journal of Antimicrobial Chemotherapy, p. 645-650, 2003
Articles, review/survey
-
Resetting the agenda for antibiotic resistance through a health systems perspective
Part of The Lancet Global Health, 2021
- DOI for Resetting the agenda for antibiotic resistance through a health systems perspective
- Download full text (pdf) of Resetting the agenda for antibiotic resistance through a health systems perspective
-
Antimicrobial resistance-a threat to the world's sustainable development
Part of Upsala Journal of Medical Sciences, p. 159-164, 2016
- DOI for Antimicrobial resistance-a threat to the world's sustainable development
- Download full text (pdf) of Antimicrobial resistance-a threat to the world's sustainable development
-
Part of The Lancet - Infectious diseases, p. 225-234, 2015
-
Access, excess, and ethics—towards a sustainable distribution model for antibiotics
Part of Upsala Journal of Medical Sciences, p. 134-141, 2014
-
The global need for effective antibiotics: moving towards concerted action
Part of Drug resistance updates, p. 68-69, 2011
-
Part of Drug resistance updates, p. 118-124, 2011
-
Protein Binding: Do We Ever Learn?
Part of Antimicrobial Agents and Chemotherapy, p. 3067-3074, 2011
-
The global need for effective antibiotics: challenges and recent advances
Part of TIPS - Trends in Pharmacological Sciences, p. 509-515, 2010
-
Part of The Lancet - Infectious diseases, p. 125-132, 2008
-
Clinical and economic impact of common multidrug-resistant gram-negative bacilli
Part of Antimicrobial Agents and Chemotherapy, p. 813-821, 2008